1. Academic Validation
  2. Increased transient receptor potential canonical 3 activity is involved in the pathogenesis of detrusor overactivity by dynamic interaction with Na+/Ca2+ exchanger 1

Increased transient receptor potential canonical 3 activity is involved in the pathogenesis of detrusor overactivity by dynamic interaction with Na+/Ca2+ exchanger 1

  • Lab Invest. 2022 Jan;102(1):48-56. doi: 10.1038/s41374-021-00665-8.
Jingzhen Zhu 1 Yi Fan 1 Qudong Lu 1 Yang Yang 1 Hui Li 1 Xin Liu 1 Hengshuai Zhang 1 Bishao Sun 1 Qian Liu 1 Jiang Zhao 1 Zhenxing Yang 1 Longkun Li 1 Huan Feng  # 2 Jie Xu  # 3
Affiliations

Affiliations

  • 1 Department of Urology, Second Affiliated Hospital, Army Medical University, Chongqing, China.
  • 2 Department of Urology, Second Affiliated Hospital, Army Medical University, Chongqing, China. [email protected].
  • 3 Department of Urology, Second Affiliated Hospital, Army Medical University, Chongqing, China. [email protected].
  • # Contributed equally.
Abstract

Transient receptor potential canonical 3 (TRPC3) is a nonselective cation channel, and its dysfunction is the basis of many clinical diseases. However, little is known about its possible role in the bladder. The purpose of this study was to explore the function and mechanism of TRPC3 in partial bladder outlet obstruction (PBOO)-induced detrusor overactivity (DO). We studied 31 adult female rats with DO induced by PBOO (the DO group) and 40 sham-operated rats (the control group). Here we report that the expression of TRPC3 in the bladder of DO rats increased significantly. Furthermore, PYR10, which can selectively inhibit the TRPC3 channel, significantly reduced bladder excitability in DO and control rats, but the decrease of the bladder excitability of DO rats was more obvious. PYR10 significantly reduced the intracellular calcium concentration in smooth muscle cells (SMCs) in DO and control rats. Finally, Na+/Ca2+ exchanger 1 (NCX1) colocalizes with TRPC3 and affects its expression and function. Collectively, these results indicate that TRPC3 plays an important role in the pathogenesis of DO through a synergistic effect with NCX1. TRPC3 and NCX1 may be new therapeutic targets for DO.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-19408
    99.42%, TRPC3 Inhibitor